Vero-Ciprofloxacin

Vero-Ciprofloxacin is an antibacterial drug from the fluoroquinolone group.

Country of origin: Russia, Ocasa Pharma India.

Manufacturers: Veropharm/Belgorod/Ocasa Pharma (Russia), Ocasa Pharma (India).

International name: Ciprofloxacin.

Synonyms: Aquacipro, Alcipro, Arflox, Afenoxin, Zindolin 250, Ificipro, Quintor, Quintor-250, Quintor-500, Laiproquin, Liproquin, Medociprin, Microflox, Neofloxin, Proxacin, Procipro, Recipro, Siflox, Tacip, Tseprova, Cefobak, Ciloxan , Ciplox, Ciprinol, Cipro.

Dosage forms: film-coated tablets 250 mg, film-coated tablets 500 mg.

Composition: Active substance - ciprofloxacin.

Indications for use: infections of the ENT organs, lower respiratory tract, pelvic organs, skin and soft tissues, bones and joints, sexually transmitted diseases, abdominal infections, bacteremia, septicemia, severe infections due to immunodeficiency and neutropenia, prevention of infections during surgical interventions . Locally - infectious and inflammatory eye diseases.

Contraindications: hypersensitivity, glucose-6-phosphate dehydrogenase deficiency, childhood and adolescence, pregnancy, breastfeeding.

Side effects: nausea, diarrhea, abdominal pain, central nervous system disorders, changes in laboratory parameters, allergic reactions, disorders of the cardiovascular system, respiratory system, genitourinary system, musculoskeletal system, skin.

Interaction: possible interaction with other drugs.

Overdose: gastric lavage, fluid administration, hemodialysis.

Special instructions: use with caution in diseases of the central nervous system, in old age, in cases of impaired renal and liver function. It is necessary to control the concentration of the drug in the blood.